By Matt Kennedy, PhD, Associate Director Molecular Virology at Oncorus and UR Alumnus
As I progressed through grad school and my postdoctoral training, I became both engrossed and inspired by my basic research, but there was always a lingering thought that I had diverged from my original intention: production of therapeutics for unmet human disease. This therapeutic direction had always been there, and as I considered the immediacy of the impact of my work, I gave serious consideration to industry scientist jobs in fast moving startups / small biotechs where I could directly contribute to new medicines.